Victor McPherson

Dr. Victor McPherson is a Urologic Oncologist who joined the McGill University Urology Faculty in 2019 after completing his Urologic Oncology training at Memorial Sloan Kettering Cancer Center in New York City. Prior to his training in New York, he completed his undergraduate studies and a MSc in Biochemistry at Queen’s University in Kingston, Ontario, followed by Medical School and Urology Residency at the University of Western Ontario in London, Ontario. His clinical interest is the surgical management of urologic cancers, with a focus on prostate, kidney and bladder cancer. His research focus is on bladder cancer, and is in the generation of clinical trials and the utilization of targeted therapeutics to shut down critical cancer cell signaling processes. He has published peer reviewed papers, presented at national and international meetings, and obtained grant funding and initiated a Phase II clinical trial evaluating the combination of metformin and simvastatin as neoadjuvant therapy for invasive bladder cancer, which currently continues to enroll at the University of Western Ontario (https://clinicaltrials.gov/ct2/show/NCT02360618).